Peter Hohenberger

20PUBLICATIONS
178CO-AUTHORS
Evolutionary ecologyPredictive and prognostic markersMolecular targetsMajor global burdens of diseaseSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 11, 2026
Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment.

|Jun 08, 2026
Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

|Apr 21, 2026
Treatment of retroperitoneal sarcoma in Germany between 2000 and 2022: a retrospective analysis from the German Cancer Registry Group.

|Mar 28, 2026
The Health-Related Quality of Life of German Desmoid Patients: Results from the PROSa-DES and PROSa Study.

Martin Eichler, Rebekka Hoffmann, Christina Baumgarten

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|Mar 05, 2025
Selective internal radiation with Y-90 resin microspheres (SIRT) for liver metastases of gastro-intestinal stromal tumors (GIST) resistant to tyrosine kinase inhibitor (TKI) therapy.

Peter Hohenberger, Nils Rathmann, Karen Büsing

Pageof 4

Frequent Collaborators

7 joint publications

Bernd Kasper

6 joint publications

Eva Wardelmann

5 joint publications

Sebastian Bauer

4 joint publications

Daniel Pink